Allelic diversity and naturally acquired allele-specific antibody responses to Plasmodium falciparum apical membrane antigen 1 in Kenya
- PMID: 20732997
- PMCID: PMC2976345
- DOI: 10.1128/IAI.00576-10
Allelic diversity and naturally acquired allele-specific antibody responses to Plasmodium falciparum apical membrane antigen 1 in Kenya
Abstract
Although Plasmodium falciparum apical membrane antigen 1 (AMA1) is a leading malaria vaccine candidate, extensive allelic diversity may compromise its vaccine potential. We have previously shown that naturally acquired antibodies to AMA1 were associated with protection from clinical malaria in this Kenyan population. To assess the impact of allelic diversity on naturally acquired immunity, we first sequenced the ectodomain-encoding region of P. falciparum ama1 from subjects with asymptomatic, mild, and severe malaria and measured allele frequency distributions. We then measured antibodies to three allelic AMA1 proteins (AMA1_3D7, AMA1_FVO, and AMA1_HB3) and used competition enzyme-linked immunosorbent assays (ELISAs) to analyze allele-specific antibodies. Seventy-eight unique haplotypes were identified from 129 alleles sampled. No clustering of allelic haplotypes with disease severity or year of sampling was observed. Differences in nucleotide frequencies in clinical (severe plus mild malaria) versus asymptomatic infections were observed at 16 polymorphic positions. Allele frequency distributions were indicative of balancing selection, with the strongest signature being identified in domain III (Tajima's D = 2.51; P < 0.05). Antibody reactivities to each of the three allelic AMA1 proteins were highly correlated (P < 0.001 for all pairwise comparisons). Although antibodies to conserved epitopes were abundant, 48% of selected children with anti-AMA1 IgG (n = 106) had detectable reactivity to allele-specific epitopes as determined by a competition ELISA. Antibodies to both conserved and allele-specific epitopes in AMA1 may contribute to clinical protection.
Figures




Similar articles
-
Limited antigenic diversity of Plasmodium falciparum apical membrane antigen 1 supports the development of effective multi-allele vaccines.BMC Med. 2014 Oct 16;12:183. doi: 10.1186/s12916-014-0183-5. BMC Med. 2014. PMID: 25319190 Free PMC article.
-
Human antibodies to recombinant protein constructs of Plasmodium falciparum Apical Membrane Antigen 1 (AMA1) and their associations with protection from malaria.Vaccine. 2004 Dec 16;23(5):718-28. doi: 10.1016/j.vaccine.2004.05.031. Vaccine. 2004. PMID: 15542195
-
Defining the antigenic diversity of Plasmodium falciparum apical membrane antigen 1 and the requirements for a multi-allele vaccine against malaria.PLoS One. 2012;7(12):e51023. doi: 10.1371/journal.pone.0051023. Epub 2012 Dec 5. PLoS One. 2012. PMID: 23227229 Free PMC article.
-
Apical membrane antigen 1: a malaria vaccine candidate in review.Trends Parasitol. 2008 Feb;24(2):74-84. doi: 10.1016/j.pt.2007.12.002. Epub 2008 Jan 15. Trends Parasitol. 2008. PMID: 18226584 Review.
-
Antibody Correlates of Protection from Clinical Plasmodium falciparum Malaria in an Area of Low and Unstable Malaria Transmission.Am J Trop Med Hyg. 2020 Dec;103(6):2174-2182. doi: 10.4269/ajtmh.18-0805. Epub 2020 Oct 27. Am J Trop Med Hyg. 2020. PMID: 33124533 Free PMC article. Review.
Cited by
-
Limited antigenic diversity of Plasmodium falciparum apical membrane antigen 1 supports the development of effective multi-allele vaccines.BMC Med. 2014 Oct 16;12:183. doi: 10.1186/s12916-014-0183-5. BMC Med. 2014. PMID: 25319190 Free PMC article.
-
Malaria immunoepidemiology in low transmission: correlation of infecting genotype and immune response to domains of Plasmodium falciparum merozoite surface protein 3.Infect Immun. 2011 May;79(5):2070-8. doi: 10.1128/IAI.01332-10. Epub 2011 Mar 7. Infect Immun. 2011. PMID: 21383051 Free PMC article.
-
A threshold concentration of anti-merozoite antibodies is required for protection from clinical episodes of malaria.Vaccine. 2013 Aug 20;31(37):3936-42. doi: 10.1016/j.vaccine.2013.06.042. Epub 2013 Jun 22. Vaccine. 2013. PMID: 23800539 Free PMC article.
-
Comparison of the impact of allelic polymorphisms in PfAMA1 on the induction of T Cell responses in high and low malaria endemic communities in Ghana.Malar J. 2021 Sep 10;20(1):367. doi: 10.1186/s12936-021-03900-1. Malar J. 2021. PMID: 34507582 Free PMC article.
-
Distinct patterns of diversity, population structure and evolution in the AMA1 genes of sympatric Plasmodium falciparum and Plasmodium vivax populations of Papua New Guinea from an area of similarly high transmission.Malar J. 2014 Jun 14;13:233. doi: 10.1186/1475-2875-13-233. Malar J. 2014. PMID: 24930015 Free PMC article.
References
-
- Anders, R. F., P. E. Crewther, S. Edwards, M. Margetts, M. L. Matthew, B. Pollock, and D. Pye. 1998. Immunisation with recombinant AMA-1 protects mice against infection with Plasmodium chabaudi. Vaccine 16:240-247. - PubMed
-
- Babiker, H. A., J. Lines, W. G. Hill, and D. Walliker. 1997. Population structure of Plasmodium falciparum in villages with different malaria endemicity in east Africa. Am. J. Trop. Med. Hyg. 56:141-147. - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources